827 related articles for article (PubMed ID: 23986225)
1. Topical treatment with the opioid antagonist naltrexone accelerates the remodeling phase of full-thickness wound healing in type 1 diabetic rats.
Immonen JA; Zagon IS; Lewis GS; McLaughlin PJ
Exp Biol Med (Maywood); 2013 Oct; 238(10):1127-35. PubMed ID: 23986225
[TBL] [Abstract][Full Text] [Related]
2. Topical treatment with the opioid antagonist naltrexone facilitates closure of full-thickness wounds in diabetic rats.
McLaughlin PJ; Pothering CA; Immonen JA; Zagon IS
Exp Biol Med (Maywood); 2011 Oct; 236(10):1122-32. PubMed ID: 21917593
[TBL] [Abstract][Full Text] [Related]
3. Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis.
McLaughlin PJ; Immonen JA; Zagon IS
Exp Biol Med (Maywood); 2013 Jul; 238(7):733-43. PubMed ID: 23788174
[TBL] [Abstract][Full Text] [Related]
4. Selective blockade of the OGF-OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing.
Immonen JA; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2014 Oct; 239(10):1300-9. PubMed ID: 25030485
[TBL] [Abstract][Full Text] [Related]
5. Propranolol improves cutaneous wound healing in streptozotocin-induced diabetic rats.
Romana-Souza B; Nascimento AP; Monte-Alto-Costa A
Eur J Pharmacol; 2009 Jun; 611(1-3):77-84. PubMed ID: 19344703
[TBL] [Abstract][Full Text] [Related]
6. Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium.
Zagon IS; Sassani JW; Myers RL; McLaughlin PJ
Brain Res Bull; 2007 Apr; 72(1):18-24. PubMed ID: 17303503
[TBL] [Abstract][Full Text] [Related]
7. Topically applied naltrexone restores corneal reepithelialization in diabetic rats.
Klocek MS; Sassani JW; McLaughlin PJ; Zagon IS
J Ocul Pharmacol Ther; 2007 Apr; 23(2):89-102. PubMed ID: 17444796
[TBL] [Abstract][Full Text] [Related]
8. Effects of plasma fibronectin on the healing of full-thickness skin wounds in streptozotocin-induced diabetic rats.
Qiu Z; Kwon AH; Kamiyama Y
J Surg Res; 2007 Mar; 138(1):64-70. PubMed ID: 17161431
[TBL] [Abstract][Full Text] [Related]
9. Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone.
Zagon IS; Sassani JW; Immonen JA; McLaughlin PJ
Clin Exp Ophthalmol; 2014 Mar; 42(2):159-68. PubMed ID: 23777539
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the OGF-OGFr pathway in diabetic bone.
Titunick MB; Lewis GS; Cain JD; Zagon IS; McLaughlin PJ
Connect Tissue Res; 2019 Nov; 60(6):521-529. PubMed ID: 30931654
[No Abstract] [Full Text] [Related]
11. Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats.
Klocek MS; Sassani JW; McLaughlin PJ; Zagon IS
Exp Eye Res; 2009 Nov; 89(5):686-92. PubMed ID: 19576213
[TBL] [Abstract][Full Text] [Related]
12. Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.
McLaughlin PJ; Sassani JW; Klocek MS; Zagon IS
Brain Res Bull; 2010 Feb; 81(2-3):236-47. PubMed ID: 19683562
[TBL] [Abstract][Full Text] [Related]
13. The diabetic rat as an impaired wound healing model: stimulatory effects of transforming growth factor-beta and basic fibroblast growth factor.
Broadley KN; Aquino AM; Hicks B; Ditesheim JA; McGee GS; Demetriou AA; Woodward SC; Davidson JM
Biotechnol Ther; 1989-1990; 1(1):55-68. PubMed ID: 2562644
[TBL] [Abstract][Full Text] [Related]
14. Ocular surface complications result from dysregulation of the OGF-OGFr signaling pathway in female diabetic rats.
Purushothaman I; Zagon IS; Sassani JW; Mclaughlin PJ
Exp Ther Med; 2021 Jul; 22(1):687. PubMed ID: 33986852
[TBL] [Abstract][Full Text] [Related]
15. Topical Naltrexone as Treatment for Type 2 Diabetic Cutaneous Wounds.
Immonen JA; Zagon IS; McLaughlin PJ
Adv Wound Care (New Rochelle); 2014 Jun; 3(6):419-427. PubMed ID: 24940556
[No Abstract] [Full Text] [Related]
16. Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat.
Zagon IS; Jenkins JB; Sassani JW; Wylie JD; Ruth TB; Fry JL; Lang CM; McLaughlin PJ
Diabetes; 2002 Oct; 51(10):3055-62. PubMed ID: 12351447
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant and anti-inflammatory potential of curcumin accelerated the cutaneous wound healing in streptozotocin-induced diabetic rats.
Kant V; Gopal A; Pathak NN; Kumar P; Tandan SK; Kumar D
Int Immunopharmacol; 2014 Jun; 20(2):322-30. PubMed ID: 24675438
[TBL] [Abstract][Full Text] [Related]
18. Topical Naltrexone Is a Safe and Effective Alternative to Standard Treatment of Diabetic Wounds.
McLaughlin PJ; Cain JD; Titunick MB; Sassani JW; Zagon IS
Adv Wound Care (New Rochelle); 2017 Sep; 6(9):279-288. PubMed ID: 28894635
[No Abstract] [Full Text] [Related]
19. Reepithelialization of the human cornea is regulated by endogenous opioids.
Zagon IS; Sassani JW; McLaughlin PJ
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):73-81. PubMed ID: 10634604
[TBL] [Abstract][Full Text] [Related]
20. [Effect of extracorporeal shock wave therapy on diabetic chronic wound healing and its histological features].
Yan X; Yang G; Cheng L; Chen M; Cheng X; Chai Y; Luo C; Zeng B
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Aug; 26(8):961-7. PubMed ID: 23012932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
